EyePoint, Inc.
EYPT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001314102
In the last 90 days, EyePoint, Inc. insiders filed 1 open-market purchase and 0 sales; 188 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in EyePoint, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 138
- +41 vs. Q3 2023
- Shares held
- 49.6M
- +15.9M (+47.1%) vs. Q3 2023
- Total value
- $1.15B
- +$876.3M (+325.5%) vs. Q3 2023
- New holders
- 56
- 40 more added
- Sold out
- 15
- 30 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EYPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 188 | $1.33B |
| Q1 2026 | 189 | $1.15B |
| Q4 2025 | 166 | $1.52B |
| Q3 2025 | 151 | $995.2M |
| Q2 2025 | 143 | $648.5M |
| Q1 2025 | 152 | $401.2M |
| Q4 2024 | 146 | $553.4M |
| Q3 2024 | 138 | $476.1M |
| Q2 2024 | 152 | $508.7M |
| Q1 2024 | 163 | $1.14B |
| Q4 2023 | 138 | $1.15B |
| Q3 2023 | 98 | $269.3M |
| Q2 2023 | 83 | $274.7M |
| Q1 2023 | 66 | $85.6M |
| Q4 2022 | 74 | $102.8M |
| Q3 2022 | 85 | $238.1M |
| Q2 2022 | 84 | $237.7M |
| Q1 2022 | 82 | $369.9M |
| Q4 2021 | 88 | $365.4M |
| Q3 2021 | 63 | $230.5M |
| Q2 2021 | 60 | $186.4M |
| Q1 2021 | 59 | $199.6M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding EyePoint, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ghost Tree Capital, LLC | 165,000 | $3.81M | 2.20% | −160,000−49.2% | Reduced |
| PFM Health Sciences, LP | 170,871 | $3.95M | 0.24% | +170,871 | New |
| Monashee Investment Management LLC | 175,000 | $4.04M | 0.71% | +175,000 | New |
| Schroder Investment Management Group | 180,000 | $4.16M | 0.01% | +180,000 | New |
| Alyeska Investment Group, L.P. | 186,840 | $4.32M | 0.03% | +186,840 | New |
| Northern Trust Corp | 239,621 | $5.54M | 0.00% | +27,906+13.2% | Added |
| VR Adviser, LLC | 250,000 | $5.78M | 0.40% | +250,000 | New |
| Susquehanna International Group, LLP | 266,031 | $6.15M | 0.01% | +140,351+111.7% | Added |
| AXA S.A. | 287,143 | $6.64M | 0.02% | −6,948−2.4% | Reduced |
| Invesco Ltd. | 288,353 | $6.66M | 0.00% | +288,353 | New |
| First Turn Management, LLC | 317,010 | $7.33M | 1.05% | +317,010 | New |
| Ikarian Capital, LLC | 368,130 | $8.51M | 2.33% | +368,130 | New |
| Lord, Abbett & Co. LLC | 370,987 | $8.57M | 0.03% | +370,987 | New |
| Woodline Partners LP | 400,000 | $9.24M | 0.10% | +400,000 | New |
| Oracle Investment Management Inc | 401,557 | $9.28M | 10.13% | +401,557 | New |
| Acuta Capital Partners, LLC | 425,128 | $9.82M | 5.53% | +125,000+41.6% | Added |
| State Street Corp | 550,609 | $12.7M | 0.00% | +17,554+3.3% | Added |
| Goldman Sachs Group Inc | 567,986 | $13.1M | 0.00% | −32,488−5.4% | Reduced |
| UBS Group AG | 574,169 | $13.3M | 0.01% | +47,321+9.0% | Added |
| Perceptive Advisors LLC | 589,646 | $13.6M | 0.30% | +589,646 | New |
| Laurion Capital Management LP | 633,409 | $14.6M | 0.52% | +633,409 | New |
| Federated Hermes, Inc. | 674,824 | $15.6M | 0.04% | +445,289+194.0% | Added |
| Geode Capital Management, LLC | 682,417 | $15.8M | 0.00% | +146,842+27.4% | Added |
| Deutsche Bank AG | 770,503 | $17.8M | 0.01% | +748,739+3,440.3% | Added |
| Jennison Associates LLC | 1,066,240 | $24.6M | 0.02% | +1,066,240 | New |
| Millennium Management LLC | 1,128,638 | $26.1M | 0.02% | +548,009+94.4% | Added |
| Citadel Advisors LLC | 1,227,278 | $28.4M | 0.03% | +168,231+15.9% | Added |
| Morgan Stanley | 1,318,897 | $30.5M | 0.00% | +1,182,076+864.0% | Added |
| Ameriprise Financial Inc | 1,536,125 | $35.5M | 0.01% | +1,525,776+14,743.2% | Added |
| T. Rowe Price Investment Management, Inc. | 1,558,675 | $36.0M | 0.02% | +1,558,675 | New |
| Vanguard Group Inc | 2,034,060 | $47.0M | 0.00% | +593,336+41.2% | Added |
| BlackRock Inc. | 2,169,306 | $50.1M | 0.00% | +339,856+18.6% | Added |
| Essex Woodlands Management, Inc. | 2,337,786 | $54.0M | 13.37% | −1,153,135−33.0% | Reduced |
| Price T Rowe Associates Inc | 2,522,704 | $58.3M | 0.01% | +1,148,358+83.6% | Added |
| Suvretta Capital Management, LLC | 4,056,847 | $93.8M | 4.29% | +564,700+16.2% | Added |
| Adage Capital Partners GP, L.L.C. | 4,466,420 | $103.2M | 0.21% | +2,729,917+157.2% | Added |
| Franklin Resources Inc | 4,640,651 | $107.2M | 0.05% | +488,206+11.8% | Added |
| Cormorant Asset Management, LP | 6,038,235 | $139.5M | 6.68% | +2,838,235+88.7% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,370,506−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −432,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −259,113−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −176,080−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −38,587−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −37,950−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −30,042−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,480−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −13,087−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −12,620−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,106−100.0% | Sold out |
| Ulland Investment Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −331−100.0% | Sold out |
| Innovis Asset Management LLC | – | – | – | – | Not filed |